ARTICLE | Company News
Xenomics deal
June 19, 2006 7:00 AM UTC
XNOM licensed exclusive diagnostic and therapeutic rights to a genetic marker for acute myeloid leukemia (AML) from researchers at the University of Perugia (Perugia, Italy). The researchers received ...